June 28, 2017
Novartis’s Erelzi cleared in Europe
Novartis ahs won European clerance for Erelzi, as the European Commission approved it for Novartis’s division Sandoz.
Pharmaceuticals, Biotechnology and Life Sciences
Novartis ahs won European clerance for Erelzi, as the European Commission approved it for Novartis’s division Sandoz.